HUP0000271A3 - Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery

Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery

Info

Application number

HU0000271A

Other languages

Original Assignee

Lilly Co Eli

Priority date

1997-08-21

Filing date

1997-08-26

Publication date

2000-10-30

1997-08-21 Priority claimed from US08/916,991 external-priority patent/US6006753A/en

1997-08-26 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2000-07-28 Publication of HUP0000271A2 publication Critical patent/HUP0000271A2/en

2000-10-30 Publication of HUP0000271A3 publication Critical patent/HUP0000271A3/en

230000001925 catabolic effect Effects 0.000 title 1
GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 title 1
238000001356 surgical procedure Methods 0.000 title 1

HU0000271A 1997-08-21 1997-08-26 Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery HUP0000271A3 (en)